Kyowa Kirin Co., Ltd.Insider trading on Orchard Therapeutics acquisition by Kyowa Kirin may raise regulatory scrutiny or reputational concerns.

The founder and CEO of an AI startup secretly pleaded guilty last year to participating in a vast insider trading scheme involving tips from lawyers at major law firms. Court records unsealed on Monday show that Arya Bolurfrushan, a former Goldman Sachs banker who founded Abu Dhabi-based AppliedAI, pleaded guilty in June 2025 after striking a deal with federal prosecutors in Boston. He admitted to conspiring to commit securities fraud, with prosecutors recommending a two-year prison sentence and forfeiture of $954,496. Bolurfrushan traded on tips from Nicolo Nourafchan, who had worked at Sidley Austin, Latham & Watkins and Goodwin Procter, and his partner Robert Yadgarov, in exchange for a cut of profits. The scheme included trading on confidential information about the acquisition of Orchard Therapeutics by Kyowa Kirin Co Ltd, earning $950,000 in profits, and a tip about Sixth Street's $5.1 billion acquisition of Enstar.
Kyowa Kirin Co., Ltd.Insider trading on Orchard Therapeutics acquisition by Kyowa Kirin may raise regulatory scrutiny or reputational concerns.
CEO pleaded guilty to insider trading, damaging company reputation and leadership credibility.
Insider trading on Sixth Street's acquisition of Enstar may raise regulatory scrutiny or reputational concerns.